Company: GMRE
Filing Date: 2025-11-14
Form Type: 424B5
Source: 0001104659-25-112543
Chunk: 13

Company: Global Medical REIT Inc.
Filing Date: 2025-11-14
Form: 424B5
Chunk 13
---
 the Change of Control Conversion Right, see “Description          
 of Series B Preferred Stock — Conversion Right upon a Change of Control.”                                                                |
| Voting 
 Rights | Holders of the Series B                                                                                                                  
 Preferred Stock generally will have no voting rights. However, if we are in arrears on dividends, whether or not authorized or declared, 
 on the Series B Preferred Stock for six or more quarterly periods, whether or not consecutive, holders of Series B Preferred             
 Stock (voting as a single class together with the holders of the Series A Preferred Stock and the holders of all other classes           
 or series of preferred stock, or preferred stock, ranking on parity with the Series B Preferred Stock with respect to the payment        
 of dividends and the distribution of assets upon our liquidation, dissolution or winding up, or parity preferred stock, and upon         
 which like voting rights have been conferred and are exercisable) will be entitled to elect two additional directors at a special        
 meeting called upon the request of at least 10% of such holders or at our next annual meeting and each subsequent annual meeting         
 of stockholders to serve on the Board of Directors until all unpaid dividends with respect to the Series B Preferred Stock and           
 such other classes or series of preferred stock with like voting rights have been paid.                                                  |
|        | In addition, the affirmative                                                                                                             
 vote or written consent of the holders of at least two-thirds of the outstanding shares of Series B Preferred Stock and each             
 other class or series of parity preferred stock with like voting rights (voting together as a single class) is required for us to        
 authorize, create, issue or increase any class or series of equity shares ranking senior to the Series B Preferred Stock or              
 to amend any provision of our charter so as to materially and adversely affect the terms of the Series B Preferred Stock. If             
 such amendment to our charter does not equally affect the terms of the Series B Preferred Stock and the terms of one or more             
 other classes or series of parity preferred stock, the affirmative vote or written consent of the holders of at least two-thirds         
 of the shares outstanding at the time of Series B Preferred Stock, voting separately as a class, is required. Holders of the             
 Series B Preferred Stock also will have the exclusive right to vote on any amendment to our charter on which holders of the              
 Series B Preferred Stock are otherwise entitled to vote and that would alter only the rights, as expressly set forth in our              
 charter, of the Series B Preferred Stock. Among other things, we may